The history and future of SABA in asthma care

Written By Guest User
Illustration by Dr Ciléin Kearns

Illustration by Dr Ciléin Kearns

Beta-agonists have been used to treat asthma for thousands of years, originally as a naturally occurring compound in the Chinese herbal medicine ‘ma-huang’. They have the ability to relax smooth muscle in the airways when it spasms or tightens, which makes breathing easier when asthma symptoms flare. In our latest publication we take a closer look at the history and future of their role in the care of asthma.

You can read the full Open Access publication, “The history and future of short‐acting beta2‐agonist therapy in asthma“, in Respirology here: http://bit.ly/hx-future-SABA

Guest User
Previous

Outpatient studies are paused to focus on COVID-19 and ICU studies
Next

Medicinal Cannabis – what are patients asking their GP’s?